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Objective:Whitematter atrophy occurs independently of lesions inmultiple sclerosis. In contrast to lesion detection,
the quantitative assessment of white matter atrophy in individual patients has been regarded as a major challenge.
We therefore tested the hypothesis that white matter atrophy (WMA) is present at the very beginning of multiple
sclerosis (MS) and in virtually each individual patient. To ﬁnd a new sensitive and robust marker for WMA we
investigated the relationship between cortical surface area, white matter volume (WMV), and whole-brain-
surface-averaged rectiﬁed cortical extrinsic curvature. Based on geometrical considerations we hypothesized that
cortical curvature increases if WMV decreases and the cortical surface area remains constant.
Methods: In total, 95 participants were enrolled: 30 patients with early and advanced relapsing–remitting MS; 30
age-matched control subjects; 30 patients with Alzheimer's disease (AD) and 5 patients with clinically isolated
syndrome (CIS).
Results: 29/30 MS and 5/5 CIS patients showed lowerWMV than expected from their intracranial volume (average
reduction 13.0%, P b 10−10), while the cortical surface area showed no signiﬁcant differences compared with
controls. The estimated WMV reductions were correlated with an increase in cortical curvature (R= 0.62, P=
0.000001). Discriminant analysis revealed that the curvature increase was highly speciﬁc for the MS and CIS
groups (96.7% correct assignments between MS and control groups) and was signiﬁcantly correlated with
reduction of white matter fractional anisotropy, as determined by diffusion tensor imaging and the Expanded
Disability Status Scale. As expected by the predominant gray andWMdegeneration inAD, no systematic curvature
increase was observed in AD.
Conclusion:Whole-brain-averaged cortical extrinsic curvature appears to be a speciﬁc and quantitativemarker for
aWMV–cortex disproportionality and allows us to assess “pure”WMAwithout being confounded by intracranial
volume. WMA seems to be a characteristic symptom in earlyMS and can already occur in patients with CIS and
should thus be considered in future MS research and clinical studies.© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).interval; CIS, clinically isolated
d Disability Status Scale; EVAL,
atedwhitematter volume; FA,
er; GMV, gray matter volume;
isition; ICV, intracranialvolume;




. This is an open access article under1. Introduction
1.1. Clinical background
Multiple sclerosis is a chronic, multifocal, demyelinating disorder of
the CNS with progressive neurodegeneration caused by autoimmune-
inﬂammatory components. MRI characteristics of the disease include
multifocal white matter (WM) and gray matter (GM) lesions, brain at-
rophy, pseudoatrophy, and occult changes in normal-appearing WM
and GM (Pirko et al., 2007; Zivadinov, 2007; Zivadinov et al., 2008),
highlighting the pathological signiﬁcance of measures beyond lesion
number and volume (Miller et al., 2002). Visualizing and measuring
tissue loss in the CNS of patients with multiple sclerosis presents
challenges, as it is inevitably easier to capture an image of conspicuous
matter, such as in tumor identiﬁcation, than it is to capture the absencethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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death.
Reduction in brain volume can occur by distinct mechanisms,
including inﬂammatory processes, such as brain oedema, and neurode-
generative events, such as the loss of myelin or axons. There is a vast
amount of evidence supporting the hypothesis that pathological changes
inWMvolume (WMV)may occur bymechanisms that are at least partly
independent of overt lesion genesis in early multiple sclerosis (Chard
et al., 2002; Filippi et al., 2012). The loss ofWM, speciﬁcally, is considered
to be of high pathophysiological relevance and not an epiphenomenon.
Brain atrophy, which can be detected very early in the disease course
of multiple sclerosis, is strongly related to disability, but is not well
reﬂected by lesion load when examined in larger cohorts (Calabrese
et al., 2007; De et al., 2010; Popescu et al., 2013; Turner et al., 2003).
1.2. Overall hypothesis
With the evolution of more sophisticated imaging techniques, the
opportunity exists to identify new, increasingly sensitive measures of
tissue loss. Such a novel tissue loss-sensitive biomarker would need to
avoid any confounding effects of intracranial volume (ICV), absolute
brain size, or absolute CSF volume, and would have to reﬂect actual
microstructural changes of the WM as well as functional deﬁcits of the
patients. One concept for such a “new” marker was inspired by an
everyday life observation (Fig. 1): that an object with signs of minimal
volumetric “atrophy”would have an increased extrinsic (mean) surface
curvature if the surface area remains largely constant while the volume
is reduced. Thus, it was hypothesized that measuring the extrinsic
curvature of the cortex may provide a reliable measure of underlying
WM atrophy.
1.3. Why measuring curvature to assess a volume?
The idea here was not to assess any absolute or relative volume. The
ideawas to assess a potential volumetric change of theWMwith a single
time point MRI. An initial (single time point) WMV estimation can
principally not be used to ensure (slight) atrophy. By deﬁnition, atrophy
is an acquired volume loss, but an initially estimatedWMV is not relatedFig. 1. Representative object (apple) with signs of minimal volumetric “atrophy”. The
wrinkled skin has an increased extrinsic curvature.to any earlier volume. Thuswequestioned ifwe couldﬁnd ameasure that
must have changed from a normal value to an obviously (quantitatively)
altered value if theWM selectively has shrunk in the past? As a potential
candidate, we identiﬁed the cortical curvature. However, if the analogy to
the apple of Fig. 1 should hold, a number of prerequisitesmust be fulﬁlled.
We have to show that: (i) the WM volume is lower in patients with MS,
(ii) the cortical surface area is not proportionally altered relative to
healthy controls, (iii) the cortical curvature of healthy subjects has less
variation than the WMV, and (iv) a volume lower than expected from
normal controls is correlated with a higher curvature.
1.4. Objective and clinical hypotheses
The objective of the present study was to investigate whether the
cortical extrinsic curvature could represent a new, robust, and sensitive
biomarker to assess loss of WM brain parenchyma in an early stage of
multiple sclerosis.
In this context, we tested the following clinical hypotheses:
• The WM is more affected than suggested by inspecting MRI slices
visually, even in patients with clinically isolated syndrome (CIS) or
early relapsing–remitting multiple sclerosis.
• Curvature as an atrophy marker is correlated to microstructural
alterations of the WM.
• The cortical extrinsic curvature (a geometric measure) is possibly a
more sensitive structural marker for selective WM atrophy than
WMV itself.
2. Materials and methods
2.1. Structure and concept of the study
To test the prerequisites to establish increased cortical curvature as
marker for a volumetric change (Section 1.3, i–iv) and to test our clinical
hypotheses,we performed a study thatwas structured into the following
analyses.
In Analysis I, we estimatedWMV and GM volume (GMV) in a cohort
of patients with early and advanced relapsing–remitting multiple
sclerosis (the multiple sclerosis group), age-matched control subjects
(the control group) and patients with expected high atrophy of the
WM and GM due to their age and a neurodegenerative condition (the
Alzheimer's disease group). We were interested in how the expected
WM atrophy of the relatively young patients with multiple sclerosis
was quantitatively related to the atrophy observed in the Alzheimer's
disease group. We further questioned how the absolute WMVs were
related to (and thus confounded by) the individual ICVs. To test the
hypothesis that effects seen in the multiple sclerosis group could
principally also occur in individuals who are potentially in a “pre-state”
of multiple sclerosis, we also included ﬁve patients with CIS (Part I-a).
In Part I-b of the study, we examined individual cortical GM measures,
i.e. the cortical GMV, cortical thickness, and cortical surface area of all
participants.
Analysis II aimed to answer thequestionwhether a potentialWM–GM
disproportion would correlate with an increased cortical extrinsic
curvature as demonstrated by the apple in Fig. 1 (Part II-a), and, if so, if
this increase would be speciﬁc to the patients in the multiple sclerosis
group (Part II-b), and how age, disease duration, and lesion load would
be related to any potential curvature alteration (Part II-c). Analysis III
should reveal if any potential geometric properties of the cortex are
associated with intrinsic microstructural alterations of the WM as they
can be determined by diffusion tensor imaging (DTI).
Analysis IV should clarify if an increase in the cortical extrinsic
curvature has any functional correlate, i.e. is related to the disease
progression as expressed by the Expanded Disability Status Scale (EDSS)
(Part IV-a), and, if so, whether this measure would better correlate with
the EDSS than the estimated individual volumetric loss of WM brain
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WM lesion load (Part IV-b).
2.2. Subjects
Thirty consecutive patients with early and advanced relapsing–
remitting multiple sclerosis (EDSS: range 1–5.5, median 1.5; disease
duration: range 14–265 months, median 71.5 months) attending our
clinic and diagnosed according to revised McDonald criteria (Polman
et al., 2011), were assigned to high-resolution structural and diffusion-
weighted MRI at 3 T (age: mean 37.9 years, median 36 years, range
26–56 years, standard deviation [SD] 8.5 years). As control subjects
(the control group), 30 age-matched neurologically and psychiatri-
cally healthy volunteers were included in the study (age: mean
38.1 years, median 34.5 years, range 23–69 years, SD 13.3 years,
t-test: t = 0.08, P N 0.93). The latter subjects were recruited by an-
nouncements in local newspapers. The only selection criterion was
age to guarantee equal age distribution between both groups. Addi-
tionally, a reference group of 30 randomly selected patients with
Alzheimer's disease— a neurodegenerative disease known to strong-
ly affect WMV and GMV was also included (age: mean 65.6 years,
range 46–72 years, SD 6.3 years). Finally, ﬁve consecutive patients
of our outpatient clinic with CIS, age-matched in relation to the
control group (age: mean 35.4 years, range 18–54 years, SD 16.5
years, t-test: t = 0.41, P N0.68) were also included.
Written informed consentwasobtained fromall 95 studyparticipants.
The participants were also informed that the examination could reveal
potentially medically signiﬁcant ﬁndings and given the option to request
notiﬁcation in the event of such ﬁndings. The interdisciplinary ethics
committee of the University of Münster and the Westphalia-Lippe
Chamber of Physicians (Ärztekammer Westfalen-Lippe) approved all
examinations.
2.3. MRI
All 95 participants (patientswithmultiple sclerosis, control subjects,
patients with Alzheimer's disease, and patients with CIS) were scanned
using the same 3 T Siemens TIM Trio MRI scanner and a 12-channel
(matrix) head coil (Siemens AG, Erlangen, Germany) and the same
parameters and protocols were applied. Images of the following MRI
sequences were obtained: a native isotropic 3D MP-RAGE T1-weighted
sequence (ﬁeld of view [FOV] 256 × 256 mm2, slice thickness 1.0 mm,
matrix 256 × 256, no gap, repetition time [TR] 2000 ms, echo time
[TE] 2.52 ms, generalized autocalibrating partially parallel acquisition
[GRAPPA] factor 2) and axial diffusion-weighted echo planar imaging
for (DTI) (41 slices, FOV 230 × 230 mm2, slice thickness 3.6 mm,matrix
128 × 128, no gap, slice order interlaced, two averages, TR 7000 ms,
TE 104 ms, phase encoding direction: anterior to posterior, 20 gradient
directions with b = 1000 s/mm2, 5× b = 0 s/mm2, 2 averages,
GRAPPA factor 2).
The followingMRI sequenceswere applied only for the patientswith
multiple sclerosis to assess lesion load: an axial turbo spin-echo (TSE)
FLAIR (44 slices, FOV 250 × 250 mm2, slice thickness 3.0 mm, matrix
256 × 256, TR 9200 ms, TE 88 ms, no gap, slice order interlaced, TI
(inversion time) 2300 ms, ﬂip angle 150°), a sagittal TSE FLAIR (32
slices, FOV 240 × 240 mm2, slice thickness 3.0 mm, matrix 256 × 256,
no gap, slice order interlaced), one 3D MP-RAGE T1-weighted after
intravenous gadolinium-DTPA (diethylene triamine penta-acetic acid)
0.1 mmol/kg injection, an axial T2-weighted TSE “short” (46 slices,
FOV 250 × 250 mm2, slice thickness 3.0 mm, matrix 256 × 256,
TR 4000 ms, TE 18 ms, no gap, slice order interlaced), an axial T2-
weighted TSE “long” (46 slices, FOV 250 × 250 mm2, slice thickness
3.0 mm, matrix 256 × 256, TR 3000 ms, TE 72 ms, no gap, slice order
interlaced, GRAPPA factor 2), and an axial proton density-weighted
TSE (46 slices, FOV 250 × 250 mm2, slice thickness 3.0 mm, matrix256 × 256, TR 3000 ms, TE 17 ms, no gap, slice order interlaced). Head
motion was minimized by foam padding.2.4. DTI data post-processing
All diffusion-weighted images were effectively corrected for eddy
currents and head movements using a recently developed algorithm
(Mohammadi et al., 2010) and a multi-contrast image registration
algorithm for the optimum spatial pre-processing of DTI data
(Mohammadi et al., 2012). The registration algorithm provided
rigorous iterativemulti-contrast registration steps based on FA contrasts
and b0 contrasts (b = 0 s/mm2), so that volumetric effects in the
resulting normalized FA maps were negligible (Mohammadi et al.,
2012). All registered diffusivity images corresponded to the MNI
(Montreal Neurologic Institute) coordinate space. For quantitative
analysis of the optimally spatially registered images, we generated two
regions of interest (ROI): one for the whole WM and the other for the
corpus callosum. These ROIs that were automatically created on the
output images had been employed and validated in earlier studies
(Deppe et al., 2007; Kleffner et al., 2008; Wersching et al., 2010). All
DTI image-processing steps (registration, eddy current correction, tensor
estimation, diffusionparameter, andROI calculation)wereperformed in a
fully automated (and thus objective) processing pipeline for quantitative
assessment of DTI data (“Münster Neuroimaging Evaluation System”
[EVAL]) (Deppe et al., 2007, 2008, 2013).2.5. Individual cortical curvature, thickness, and area analysis
All 3DMP-RAGE images were also transferred to the EVAL andwere
corrected for lack of homogeneity in intensity using in-house software.
All images were automatically processed by software scripts in exactly
the same way on an Apple® Mac Pro (OS X 10.7, 32 GB, 2 × 2.93 GHz
6-Core Intel Xeon, Apple® Inc., Cupertino, CA, USA) running FreeSurfer
software (Version 5.1; http://surfer.nmr.mgh.harvard.edu/). For details
of this method see Dale et al. (1999), Fischl (2012), Fischl and Dale
(2000) and Fischl et al. (1999). Brieﬂy, cerebral WM was initially
segmented, divided into two hemispheres, and the brainstem and
cerebellum were removed. A triangle-based mesh of the WM surface
is produced through tessellation, which is subsequently deformed
outward to generate the pial surface before automatic correction of
topological defects in the resulting main fold. Cortical thickness mean
and Gaussian intrinsic curvature measurements were obtained at each
vertex by reconstructing representations of the GM–WM boundary and
the pial surface. The entire cortex of each patient and control was visually
inspected, but no relevant errors in cortical labeling could be detected that
had to be manually corrected. Thus the whole quantitative brain analysis
was completely objective and could not be biased by any subjective factor.
Local cortical thickness, rectiﬁed extrinsic and Gaussian curvature had
been averaged over both cerebral hemispheres using software tools
incorporated into FreeSurfer software for each examined individual.
Additionally, we calculated the individual total cortical surface area.
From the segmented data, we used the cortical WMV and the cortex
volume as calculated by FreeSurfer. By summarizing the volumes of
WM hypointensities as detected by FreeSurfer in the 3D T1w images
we assessed the individual WM “lesion load”.2.6. Group analysis
For the group analyses of all estimated end points, methods based on
theGeneralized LinearModel (t-test, ANOVA, ANCOVA) anddiscriminant
function analysis as provided by the software STATISTICA Version
10 (2011; Stat Soft. Inc., Tulsa, OK, USA) were employed. All reported
signiﬁcant results survived criteria for multiple comparisons.
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3.1. (Analysis I-a) Patients with multiple sclerosis show WM atrophy
comparable to the elderly patients with Alzheimer's disease
An ANOVA (dependent variable WMV, factors: group [control,
multiple sclerosis, Alzheimer's disease group] and gender [female,
male]) revealed signiﬁcant main effects for group and gender; [group:
F(2, 84) = 7.1, P= 0.0014; gender: F(1, 84) = 15.4, P= 0.00017]. No
signiﬁcant group × gender interaction could be observed [F(2, 84) =
1.7, P = 0.18]. The ﬁve CIS patients were not included in the analysis.
Post-hoc t-tests revealed that the multiple sclerosis patients showed a
13.0%WMV reduction in relation to the control group (multiple sclerosis:
mean WMV = 456,303 mm3, SD 63,116 mm3; control: WMV =
524,329 mm3, SD 68,318 mm3; P b 0.0002). The WMV reduction was
comparable to the volume reduction of 15.6% seen in the older group of
patients with Alzheimer's disease (WMV = 442,631 mm3, SD
59,574 mm3; P b 0.00001). No signiﬁcant differences in WMV could be
found between the multiple sclerosis and Alzheimer's disease groups,
and between the multiple sclerosis and CIS groups. The results are
illustrated in Fig. 2 and summarized in Table 1.
WMV was strongly correlated with ICV in the control group (R =
0.876; P b 0.0000001; control WMV = −61,420 mm3 + 0.3881 ×
control ICV), so that 77% of the WMV variance could be explained by
the ICV in the control group (Fig. 3). We used the “control WMV” as
the ICV-dependent predictor for the expected WMV (eWMV) in the
multiple sclerosis group:
eWMV ¼−61;420 mm3 þ 0:3881multiple sclerosis ICV: ð1Þ
The difference between “actual multiple sclerosis WMV” in each
individual patient and eWMV was calculated as:
ΔWMV ¼ actual multiple sclerosis WMV–eWMV: ð2ÞFig. 2.Whitematter volumes. Groupmean values and signiﬁcance levels as reported by ANOVA
(MS) showed a relevant (13.0%)WM atrophy, that is comparable to that of (much older) patien
mean. CTRL = control.The arrow in Fig. 3 illustrates theΔWMVof one patient. Themultiple
sclerosis patients showed a highly signiﬁcant negative ΔWMV
compared with the control subjects (mean multiple sclerosis
ΔWMV = −56,417 mm3, SD = 43,267 mm3, t = −5.68; P b
0.000001). Although the number of CIS patients was very low,
and thus also the power of the t-test, the CIS patients also showed
a signiﬁcant negative ΔWMV compared with the control subjects
(mean CIS ΔWMV = −49,188 mm3, SD = 18,048 mm3, t = −3.23;
P b 0.003). The ΔWMV of the control group was about 0 mm3 because
the regression function was estimated by this group. No indication of a
systematic difference in ICV between the control and multiple sclerosis
groups could be found (multiple sclerosis: 1.48 l, SD = 0.13 l, control:
1.51 l, SD= 0.15 l t=0.82; P N 0.42). The samewas true for the patients
with Alzheimer's disease (1.48 l, SD = 0.14 l, t= 0.66; P N 0.51).
3.2. (Analysis I-b) Multiple sclerosis patients and controls showed no
signiﬁcant or relevant differences in cortical surface area
An ANCOVA (dependent variable: cortex volume, categorical
factors: gender [female, male] and group [control, multiple sclerosis,
Alzheimer's disease], continuous factor: age) showed a signiﬁcant
gender effect [F(1, 83) = 16.66, P = 0.0001], group effect [F(2, 83) =
3.80, P b 0.05], and age effect [F(1, 83) = 12.78, P b 0.001], but no
group × gender effect [F(2, 83) = 0.28, P = 0.76]. A post-hoc analysis
showed that the cortical volumes differed signiﬁcantly (7.17%) between
the control and multiple sclerosis groups (multiple sclerosis: mean
cortex volume = 480,723 mm3, control: mean cortex volume =
517,863 mm3, P b 0.05). The patients with Alzheimer's disease
showed a highly signiﬁcant (22.87%) decrease in cortical volume
(mean cortex volume = 399,414 mm3; P b 10−9).
An ANCOVA (dependent variable: cortical thickness, categorical
factors: gender [male, female] and group [control, multiple sclerosis,
Alzheimer's disease], continuous factor: age) revealed that age and
group had a highly signiﬁcant main effect on cortical thickness [age:
F(2, 83) = 16.8; P b 0.000001; group: F(2, 83) = 14.6; P b 0.000001].(dependent variableWMV, factors: group and gender). Thepatientswithmultiple sclerosis
ts with Alzheimer's disease (AD). Vertical bars denote the SD and the box the 95% CI of the
Fig. 3. TheWMVwas strongly correlatedwith the ICV in both themultiple sclerosis (MS) and control groups (CTRL). Nearly everymultiple sclerosis patient (29/30) showed a lowerWMV
(=negative “ΔWMV”, see arrow) as expected from the relationship between theWMV and ICV of the control group (blue line). The ﬁve patients with CIS also had a systematically lower
WMV, as expected from their ICV. For details, see text.
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thickness [gender: F(1, 83) = 0.0014, P = 0.97; group × gender: F(2,
83)= 0.24, P=0.78]. Themultiple sclerosis patients showed a 3.6% re-
duction in cortical thickness relative to the control group, while the
thicknesswas reduced by 10.4% in the patientswith Alzheimer's disease
(multiple sclerosis: mean thickness= 2.42, 95% conﬁdence interval [CI;Fig. 4. Cortical thickness. Boxes denote the standard error of themean and vertical bars the SD of
thickness relative to the control group (CTRL), while the thickness was reduced by 10.4% in th2.38, 2.46]; control: mean thickness = 2.51, 95% CI [2.48, 2.55],
Alzheimer's disease: mean thickness = 2.23, 95% CI [2.19, 2.27]). The
latter results are illustrated in Fig. 4.
An ANOVA (dependent variable: cortical surface area, two factors:
group [control, multiple sclerosis, Alzheimer's disease] and, gender
[female, male]) revealed a signiﬁcant group main effect [F(2, 84) =cortical thickness. Themultiple sclerosis (MS) patients showed a 3.6% reduction in cortical
e patients with Alzheimer's disease (AD).
Fig. 5. Cortical surface area. Multiple sclerosis (MS) patients showed no signiﬁcant (4%) decrease in cortical surface area compared with normal control subjects (CRTL) in contrast to the
group of patients with Alzheimer's disease (AD; 12.8%).
480 M. Deppe et al. / NeuroImage: Clinical 6 (2014) 475–48711.442, P=0.00004] and a signiﬁcant gender main effect [F(1, 84)=
31.199, P b 0.000001], but no signiﬁcant group × gender effect [F(2,
84) = 1.46, P = 0.24]. Post-hoc t-tests showed that the group main
effect could be attributed to the Alzheimer's disease group (see
Fig. 5). The multiple sclerosis patients showed no signiﬁcant (4%) de-
crease in cortical surface area compared with the normal controlFig. 6. Integrated cortical extrinsic curvature increases with estimated WMV loss (ΔWMV) in m
highest cortical curvature (left arrow). The dashed lines have been calculated by discriminant
details see text. The letters depict the example control (CTRL) subject (“A”) and the multiple ssubjects (multiple sclerosis: mean area = 181,652 mm2, SD =
17,011 mm2; control: mean area = 189,309 mm2, SD =
21,104 mm2, t = 0.55, not signiﬁcant). The group of patients with
Alzheimer's disease showed a highly signiﬁcant 12.8% reduction in
cortical surface area (mean area = 165,006 mm2, SD = 18,408 mm2;
P b 0.0001).ultiple sclerosis patients. Patients with a relatively high estimatedWMV loss showed the
function analysis to assess the classiﬁcation power of ΔWMV and extrinsic curvature. For
clerosis (MS) patient (“B”) referred to in Fig. 8.
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curvature in patients with multiple sclerosis
An overall linear regression between cortical extrinsic curvature and
ΔWMV of the multiple sclerosis and control groups revealed a strong
relationship between individual cortical extrinsic curvature and
eWMV loss: ΔWMV (R = 0.62, P = 0.000001). Although the ΔWMV
and cortical extrinsic curvature were strongly correlated, the
results of a discriminant function analysis qualiﬁed the extrinsic
curvature as the better predictor of classiﬁcation into the control
and multiple sclerosis groups (grand class means for classiﬁcation:
ΔWMV=−26,091 mm3, 83.3% correct classiﬁcations, cortical extrinsic
curvature = 0.1548 mm−1, 93.7% correct classiﬁcations) (see Fig. 6).
Patients with a relatively high eWMV loss showed the highest cortical
curvature (linear regression within the multiple sclerosis group: R =
0.44, P = 0.01). No correlation was found by a group-wise regression
analysis within the control group (R= 0.033, P= 0.86).
3.4. (Analysis II-b) The individually increased cortical extrinsic curvature
seems to be speciﬁc to a WM–GM disproportion
The ANCOVA with dependent variable cortical extrinsic curvature
and categorical factors gender [female, male], group [multiple sclerosis,
control, Alzheimer's disease], and continuous predictor age revealed
that the factor group had the largest main effect on the cortical
curvature [F(2, 83)= 40.0; P b 0.0000001], age produced no signiﬁcant
effect (F = 0.3; P N 0.60), while the curvature is slightly inﬂuenced by
gender [F(1, 83) = 12.1; P b 0.001], but no group-speciﬁc gender effect
could be observed [gender × group effect: F(2, 83) = 1.3, P = 0.27].
Post-hoc t-tests demonstrated that the multiple sclerosis patients
showed a highly signiﬁcant 13.3% increase in cortical curvature in
relation to the age-matched control group (multiple sclerosis:
extrinsic curvature= 0.165mm−1, SD 0.0057mm−1; control: extrinsic
curvature = 0.146 mm−1, SD 0.0057 mm−1, P b 10−10). The CIS group
also showed a signiﬁcantly increased cortical extrinsic curvature (CIS:
extrinsic curvature = 0.161 mm−1, SD 0.0044 mm−1, P b 0.0001). TheFig. 7. Cortical extrinsic curvature. Themultiple sclerosis (MS) patients showed on average a hig
control (CTRL) group. The CIS group also showed a signiﬁcantly increased cortical extrinsic curgroup of patients with Alzheimer's disease showed no change in cortical
curvature in relation to the control group (Alzheimer's disease: extrinsic
curvature=0.145mm−1, SD 0.0128mm−1, P=0.88). These results are
summarized in Fig. 7.
A representative example subject from each of the three groups
(control, multiple sclerosis, and Alzheimer's disease) is shown in Fig. 8
to illustrate how the mathematically abstract value of rectiﬁed extrinsic
curvature is associated with the individual appearance of sulci and gyri
in corresponding T1-weighted MRI slices. Fig. 9 illustrates how the
local extrinsic curvature was determined for the same control subject
and multiple sclerosis patient shown in Fig. 8 by FreeSurfer software.
3.5. (Analysis II-c) Impact of disease duration, age, lesion load, and ICV on
cortical extrinsic curvature
Neither the multiple sclerosis nor the control group showed a
signiﬁcant impact of age on cortical extrinsic curvature. In addition,
the disease duration had no signiﬁcant impact on the curvature.
Additionally, already the 4 CIS and 5 RRMS patients with a disease
duration of less than 24 months showed curvatures above the values
of nearly all normal controls. The results are illustrated as a scatterplot
in Fig. 10. In contrast to the WMV, the whole-brain-averaged cortical
extrinsic curvature showed virtually no ICV dependence in the control
group (R = 0.096, P = 0.62). A linear regression with dependent
variable cortical extrinsic curvature and factor lesion load showed a
weak positive correlation between curvature and lesion load in the
group of patients with multiple sclerosis (R= 0.33, P= 0.07).
3.6. (Analysis III-a) Microstructural correlate within the WMV of increased
cortical extrinsic curvature
The mean FA values of the corpus callosum ROI were signiﬁcantly
reduced in the multiple sclerosis group compared with the control
group (multiple sclerosis: mean FA 0.365, SD 0.0618; CIS: mean
FA 0.398, SD 0.031; control: mean FA 0.420, SD 0.0397, t = 4.11,
P b 0.0002). A linear regression analysis of the mean FA within thehly signiﬁcant 13.3% increase in cortical extrinsic curvature in relation to the age-matched
vature. Vertical bars denote SDs and boxes standard errors.
Fig. 8. Illustration of the increased cortical curvature in a patient with multiple sclerosis and quantiﬁedWM atrophy relative to a control subject and a patient with Alzheimer's disease.
Shown are coronal and sagittal sections of a healthy control subject (A), a patient with multiple sclerosis (B), and a patient with Alzheimer's disease (C). The T1-weighted MRIs are
superimposed by structural labels of cortical surfaces (yellow, red), WM (green, white) and cortex (brown) as generated by FreeSurfer software. The mean rectiﬁed curvatures of the
left (green) and right (white) hemispheres were 0.135 mm−1 (left hemisphere [lh])/0.135 mm−1 (right hemisphere [rh]) for the control subject and 0.179 mm−1 (lh)/0.168 mm−1
(rh) for the patient with multiple sclerosis. Cortical WMV was about 15% less in the multiple sclerosis patient relative to the control subject (control: 266,960 mm3 [lh], 267,879 mm3
[rh]; multiple sclerosis: 219,878 mm3 [lh], 225,045 mm3 [rh]) and about 33% less in the patient with Alzheimer's disease (181,802 mm3 [lh], 179,325 mm3 [rh]). By comparing A and
B, the increased curvature (N24%) and the WM atrophy can be clearly seen in the patient with multiple sclerosis, while the patient with Alzheimer's disease has obvious WM atrophy,
but the cortical curvature looks not only similar to that of the control subject, but is also quantitatively very close to the control subject (0.139 mm−1 [lh]/0.138mm−1 [rh]). The average
cortical thicknesses showed no relevant (b2%) differences between the control subject, the multiple sclerosis patient, and the patient with Alzheimer's disease (control: 2.344 mm [lh],
2.357 mm [rh]; multiple sclerosis: 2.314mm [lh], 2.338 mm [rh]; Alzheimer: 2.391 mm [lh], 2.357mm [rh]). In addition, the total surface areas of the hemispheres of the control subject
and themultiple sclerosis patient showed no relevant (b2%) differences (control: 87,562mm2 [lh], 87,565mm2 [rh]; multiple sclerosis: 86,202mm2 [lh], 89,116mm2 [rh]). In contrast to
the multiple sclerosis patient, the patient with Alzheimer's disease has an about 20% smaller cortical surface relative to the control subject (70,957 mm2 [lh], 70,029 mm2 [rh]).
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curvature in patients with multiple sclerosis was signiﬁcantly
correlated with the WM integrity loss as assessed by FA (“extrinsic
curvature” = 0.178 mm−1 − 5.0 × 10−2 mm−1 × “FA in corpus
callosum”, R = 0.50, P = 0.006). For details see Fig. 11.
3.7. (Analysis III-b) Sensitivity and speciﬁcity
The two end points “WM integrity loss as assessed by FA” and “aver-
aged cortical extrinsic curvature” allowed a highly speciﬁc classiﬁcation
of the 60 examined age-matched subjects into the control and multiple
sclerosis groups (Fig. 12). The patients of the Alzheimer's disease group
showed predominantly low cortical extrinsic curvature, like the control
subjects, but signiﬁcantly reduced FA (mean Alzheimer's disease: 0.318,
mean control: 0.361, t =−7.33; P b 0.000000001). Interestingly, the
68% probability ellipses of the patients with CIS strongly overlapped
with themultiple sclerosis group, but not with the ellipse of the control
group.
3.8. (Analysis IV-a) Does WMV atrophy as expressed by the cortical extrinsic
curvature have a functional correlate?
A linear regression analysis (Fig. 13) between the EDSS and cortical
extrinsic curvature showed that the disease progression of multiple
sclerosis, as assessed by the EDSS, is related to an increased cortical
extrinsic curvature (linear regression analysis: dependent factor:
EDSS, independent factor: cortical curvature, R = 0.38, P = 0.05). It
should be noted here that the EDSS represents a rank ordering of
observations (ordinal) rather than a precise measurement of an actualcontinuous variable. However, the EDSS was assessed in half-steps so
that its variability can be considered as quasi-continuous.
3.9. (Analysis IV-b) Which measure better predicts disability: estimated
volumetric loss of WM brain parenchyma (ΔWMV), cortical thickness,
lesion load, or curvature increase?
Cortical extrinsic curvature increase seemed to be a better predictor of
functional deﬁcits than the estimated ΔWMV, i.e. correlated signiﬁcantly
with the EDSS in contrast to the ΔWMV (linear regression with
dependent variable: EDSS, factor: ΔWMV, R= 0.30, P= 0.10). Also the
WMlesion load and the graymatter volumedidnot correlate signiﬁcantly
with the EDSS (linear regression with dependent variable: EDSS, factor:
lesion load, R = 0.27, P = 0.12, factor gray matter volume, R = 0.04,
P = 0.82). In addition, individual average cortical thickness of the
patients with multiple sclerosis was also not a better predictor of the
EDSS than the cortical extrinsic curvature (linear regression dependent
variable EDSS, factor cortical thickness R= 0.16, P= 0.40).
4. Discussion
4.1. Increased cortical extrinsic curvature and WMV loss
The main ﬁnding of the present study is that increased cortical
extrinsic curvature was observed in patients with multiple sclerosis
compared with control subjects and patients with Alzheimer's disease.
Most notably, an increased cortical curvature was even shown in
patients with CIS, a potentially early sign of multiple sclerosis. It is
hypothesized that the curvature increase was most likely caused by
WM atrophy in each individual subject (Figs. 3, 6, and 10) and arose
Fig. 9. Illustration of the estimated local cortical extrinsic curvature in the sample control subject (A–C) and the sample patient with multiple sclerosis (D–F) of Fig. 8. Shown are slightly
smoothed local extrinsic curvatures of the cortex (pial surface) (A, D) andWMsurface (B, E). Negative regions are folded-out and shown in green (gyral), and positive regions are folded-in
and shown in red (sulcal). In this study, we only considered the “folding” or extrinsic (mean) curvature,which is deﬁned at every point P on the surface (for details see text books). At each
point P, the extrinsic curvature of a plane curve can be illustrated as the inverse of the radius r of the osculating circle, a circle with a certain tangency and curvature so that it best ﬁts the
curve in a certain point P (curvature= 1 / r). TheWM surface of themultiple sclerosis patient (E) looked obviously “shrunken”with sharper edges at the outer gyri when compared with
the WM surface of the control subject (B) with normal WMV.
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reduction of 13.0% was seen in the multiple sclerosis group, with 29/30
patients showing a negative ΔWMV; in contrast, there were no relevant
differences seen in cortical volume or surface area between the patients
with multiple sclerosis and the control group (Figs. 4 and 5).
The increased cortical extrinsic curvature in the multiple sclerosis
group is not an abstract mathematical expression from differential
geometry, but can actually be seen in MRI slices when compared with
subjects with an average curvature (Fig. 8A, B). The WM shrinkage is
also visible, if 3D reconstructed WM surfaces are compared (Fig. 9)
(see also Voets et al., 2011). An increased cortical extrinsic curvature
seems to be speciﬁc to primary WMV loss and a nearly (but not fully)
intact cerebral cortex. In patients with neurodegenerative Alzheimer's
disease, it can be assumed that because of the disease and the age ofFig. 10. Cortical mean curvature related to disease duration (A) and age (B). No signiﬁcant impa
tiple sclerosis; CTRL = control.these patients, the cortex and WM were degenerated. There was no
systematic disproportion of WMV and cortical GM surface, and, thus,
no systematic change in the cortical curvature (Fig. 7). Thisﬁnding further
supports the hypothesis that the WM–GM disproportion is causative of
the increased extrinsic curvature.
4.2. Estimation of reduced WMV by ΔWMV
TheWMV loss in our studywas assessed by an apparent peculiarnew
measure, i.e. ΔWMV. The rationale in favor of this method and against
ICV-normalized WM volume or WM fraction was, that ΔWMV is obvi-
ously not confounded by whole brain/GM atrophy. A second reason
was that ΔWMV allowed easily assessing the absolute volume differ-
ence compared to the expectation value of normal controls, i.e. act of disease duration or age could be observed on cortical extrinsic curvature. MS=mul-
Fig. 11.Reduction of FA in the corpus callosumwas signiﬁcantly correlatedwith the increase in cortical curvature inmultiple sclerosis patients. The three orthogonal brain sections illustrate the
ROI employed for averaging the FA of the corpus callosum. Note: the patient with the strongest FA reduction (FA close to 0.200)was regarded as an outlier and excluded from the estimation of
the regression function, because the total GMVof this patient (female, 56 years, disease duration 179month, relapsing–remittingmultiple sclerosis)was also extremely and untypically reduced
relative to the other multiple sclerosis patients (19% reduction, P b 0.05), theWM lesion volumewas 400% increased relative to the mean of the other multiple sclerosis patients (P b 0.00005)
and the cortical WMVwas reduced by 33.5% (P b 0.01) relative to the other multiple sclerosis patients.
484 M. Deppe et al. / NeuroImage: Clinical 6 (2014) 475–487negative value makes immediately clear that the volume is XY mm3
below the normal average. The calculation of an expectation value for
normal WMV was possible due to the strong linear relation between
ICV and WMV in healthy controls (Fig. 3). However, it should be noted
here, that a negative ΔWMV does not automatically mean that the
WM is atrophic. Fifty percent of the healthy subjects have per deﬁnition
a negative ΔWMV.Fig. 12. Cortical curvature in relation to microstructural WM integrity as assessed by FA. The ov
brain sections). The ellipses represent the areas of 68% probability to ﬁnd a subject of the corres
multiple sclerosis.4.3. Volume loss and microstructure
To investigate how increased extrinsic curvature is related to potential
microstructural alterations of the WM, we employed DTI to assess
microstructural tissue damage in normal-appearing WM (Deppe et al.,
2008; Duning et al., 2010; Keller et al., 2013). For this purpose, we
calculated the FA within a ROI outlining the corpus callosum. The corpuserall microstructural WM integrity was assessed by the mean FA of a wholeWM ROI (see
ponding group (“two-dimensional SD”). AD=Alzheimer's disease; CTRL= control;MS=
Fig. 13. A more severe EDSS was reﬂected by an increased cortical curvature (P b 0.05).
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damage in conjunction with WM atrophy in the normal-appearing WM
of the corpus callosum in postmortem brains of patients with multiple
sclerosis was already demonstrated by using quantitative measures of
both axonal density and WM atrophy (Evangelou et al., 2000). Secondly,
the corpus callosum contains virtually no crossing ﬁbers, so that this ROI
seemed particularly qualiﬁed to quantify neuronal integrity loss by FA
derived from a second-order tensor model (Deppe et al., 2007). Thirdly,
a recent study (Mohammadi et al., 2012), showed that volumetric or
atrophic effects on the registered diffusion-weighted images are
negligible in the corpus callosum if our newly developed rigorous
spatial normalization is employed for quantitative FA comparisons.
As expected, the FA in the corpus callosum was signiﬁcantly reduced
in the multiple sclerosis group, which can be interpreted as a kind of
physical microstructural “thinning-out” effect that leads to a loss of
diffusion barriers within the WM. Moreover, within the multiple
sclerosis group, the individual FA reduction was signiﬁcantly correlated
with the individual increase in extrinsic curvature; thus, pointing to an
association between individual WMV reduction and microstructural
WM damage (Fig. 11). These ﬁndings of early FA and volume reduction
in the corpus callosum are congruent with previous studies showing
early degeneration of the corpus callosum over 1 year following the
ﬁrst acute inﬂammatory episode in patients with multiple sclerosis
(Audoin et al., 2007; Ranjeva et al., 2003). A second ROI, encompassing
the whole WM, showed very similar effects to those seen in the corpus
callosum ROI; therefore, it seems likely that ﬁndings in the corpus
callosum are representative of the whole WM (Fig. 12).
4.4. Cortical thickness
A low, but signiﬁcant reduction in cortical thickness was seen in the
multiple sclerosis versus the control group (3.6%). This seems relatively
small compared with other studies (Calabrese et al., 2007, 2013), but
may be explained by the low degree of patient disability in the study
presented here. In a histological study, relative neocortical thinning of
10% was reported in patients with multiple sclerosis (Wegner et al.,
2006). In contrast to the ﬁndings of Sailer et al. (2003), a signiﬁcantrelationship between EDSS and cortical thickness was not established
in this study, which may be due to the lack of effect on the cortical
GM. However, one patient in our multiple sclerosis group (described
as an “outlier” in Fig. 11) differed signiﬁcantly from the other patients
due to their signiﬁcantly low GMV. Interestingly, the curvature of
this patient was less increased than other multiple sclerosis patients,
as would be expected when the WM and GM are both atrophic and,
therefore, virtually no GM–WM disproportion exists.
4.5. Reliability of cortical curvature estimates
The reliability of the FreeSurfer program for cortical reconstruction,
GMV andWMV, and cerebral surface measurements has been assessed
previously in a number of studies (Han et al., 2006; Kang et al., 2012b;
Keller et al., 2012; Lee et al., 2006; Rosas et al., 2002) and cortical
curvature analysis has also been performed on different neurological or
psychiatric patients (Ronan et al., 2011b, 2012; Voets et al., 2011). The
inter-individual variability of 3.92% (CV%) in whole-brain-averaged
absolute extrinsic curvature (see Table 2) was considerably smaller
than the variability of the absolute WMV in our control group (13.03%;
see Table 1). The low variability in the cortical extrinsic curvature of
less than 4% is remarkable, because no normalization to ICV, age, or
gender was employed. The cortical extrinsic curvature, therefore, seems
to represent a robust and sensitive biomarker for the detection of changes
in the GM–WMproportion. A previous study in healthy controls showed
mean values of 0.138 mm−1 for the whole-brain-averaged cortical
curvature and 2.585 mm for average cortical thickness (Kang et al.,
2012a), which seem to differ from the values reported in this paper.
However, if we assume that both scanners differed in linear length
calibration by a factor f = 2.59 mm/2.50 mm, their average extrinsic
curvature would result in f × 0.138 mm−1 = 0.143 mm−1 and would
thus ﬁt well into the 95% CI of the whole-brain-averaged absolute
extrinsic curvature of healthy persons seen in this study. This observation
may suggest that even small differences in geometric size calibrations
may be important when comparing quantitative results between
different scanners or system conﬁgurations (see also Han et al., 2006).
In Fig. 10, there seems to be a slight age dependent trend of a decreasing
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signiﬁcant), but would also ﬁt with the ﬁnding that the WMV is less
affected in “healthy” aging than the GMV (Grossman et al., 2002;
Vernooij et al., 2008).
4.6. Consideration of intrinsic curvature
Two types of cortical curvature may be examined in patients with
multiple sclerosis. Theﬁrst type, the extrinsic curvature ormean curvature,
is a curvature that arises from the mechanical folding of the surface, and,
as such, is not a property of the surface itself, but rather of how it is
embedded in a three-dimensional (3D) space. Extrinsic curvature
changes, if a bendable, but non-elastic two-dimensional surface is
folded within a 3D space. For example, if we roll up a ﬂat piece of
paper into a cylinder, the extrinsic curvature c changes, but not the
second type, the Gaussian (or intrinsic) curvature. In a bendable, but
non-elastic, and non-stretchable surface,we cannot change the intrinsic
curvature without destroying the surface. For example, it is not possible
to ﬁt a piece of paper (Gaussian curvature = 0.0 mm−2) to the surface
of a sphere (Gaussian curvature = 1 / R2) without producing folds and
tears (Ronan et al., 2011a).
In the present study, we concentrated on the extrinsic or mean
curvature. FreeSurfer software also measures Gaussian (or intrinsic)
curvature of the cortex. The intrinsic curvatures of the patients' cortices
were also signiﬁcantly affected by the atrophy, but showed higher
intra-group variability, were less signiﬁcantly reduced (t = 4.18,
P = 0.0001), and were not so speciﬁc than the extrinsic curvatures.
Thus, the results about the intrinsic curvature were not reported in
detail here.
4.7. Functional relevance of cortical extrinsic curvature increase
Individual disability as expressed by the EDSS was better explained
by the extrinsic curvature increase of a patient than by the estimated
individual volumetric loss of WM brain parenchyma (ΔWMV) or the
WM lesion load (Part IV-b). The weak correlation between EDSS and
lesion load might be explained by the fact that the (scalar) measure
“lesion load” is per se a rather insensitive index because it does not
account for the varying functional relevance of different lesion sites.
However, it seems to be interesting for further studies to compare how
T2w/FLAIR lesions would be correlated to cortical curvature alterations.
4.8. Methodological limitations and future research directions
The results presented here are based only on one single observation
per patient, and more assessments over time would be required to
deﬁne cortical curvature as a longitudinal biomarker of WM atrophy.
Furthermore, this study did not examine the prognostic value of the
cortical extrinsic curvature for disease progression. The pre-diagnostic
levels ofWM in these patients are unknown; thus, the degree of atrophy
over time and with increasing severity of illness cannot be elucidated.
The use of the EDSS as an indicator of disease progression has known
limitations due to subjective error and inter-rater variability (Reilmann
et al., 2013). Our group of patients with Alzheimer's disease was not
age-matched to our control group, as this group served only as a reference
for patients with pronounced WM and GM alterations.
This study did not account for the presence of cortical lesions, which
potentially could affect the cortex segmentation and reconstruction and
could, therefore, also affect local estimates of cortical curvature. However,
inspection of the T2-weighted and FLAIR images revealed that relevant
lesion load could not be observed in our multiple sclerosis group, thus,
the cortical GM was likely intact in these patients. In context with the
ﬁnding that nearly every patient showed an increased curvature, it is
very unlikely, that the increase is relevantly driven by lesions. This
hypothesis would be further supported by the fact that the multiple
sclerosis patients had only a small reduction in cortical thickness anda cortical GMV in the range of the control group, with the exception of
one patient.
This study did not explore any relationship between the curvature
alterations and lesion load in multiple sclerosis patients. This might
form the basis of future investigations in larger sample groups to
explore the effects of speciﬁc lesion patterns, like those demonstrated
in the study by Giorgio et al., which showed regionally different effects
on cortex geometry (Giorgio et al., 2013). It would also be of interest to
study WM–GM disproportionality with further quantitative MRI
measures, such as myelin water fraction (Kitzler et al., 2012), MRI
spectroscopy measures, and histopathology, in order to investigate
which predominant factor drives the WM–GM disproportionality
and thus the WMV loss. From a translational point of view, it would
be also interesting whether cortical curvature correlates better
with higher cognitive functions than conventional structural marker
like lesion load or volumetric atrophy marker.
5. Conclusion
The present ﬁndings provide further evidence that WM atrophy is
already present at the very beginning of multiple sclerosis and in
every patient suffering with this illness. The increased cortical extrinsic
curvature could be used to classify 29/30 patients to themultiple sclerosis
group, thus providing a sensitive indicator of WM loss. Overall, the
average WM atrophy that we estimated in these 30 patients was 13%,
which would be difﬁcult to visualize with conventional MRI methods
(2D slices, thickness N 2 mm). However, the speciﬁc curvature increase,
used as a surrogate measure of WM–GM disproportionality and
correlating with FA and EDSS, suggested that WM reduction in this
populationwithmultiple sclerosismight be involved in the pathological
disease processes that occur independently of GM degeneration. Thus,
WM–GM disproportionality and the cortical curvature measurement
should be considered as a potential monitoring tool in this devastating,
degenerative disorder, and this warrants further assessment in future
multiple sclerosis research.
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